InvestorsHub Logo
Followers 0
Posts 28
Boards Moderated 0
Alias Born 12/17/2019

Re: None

Monday, 11/16/2020 2:33:11 AM

Monday, November 16, 2020 2:33:11 AM

Post# of 326
ObsEva SA Reports Positive Topline Results of the PROLONG Proof-of-Concept Trial of Ebopiprant (OBE022) for Treatment of Preterm Labor
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OBSV News